AgomAb Therapeutics NV Statistics

NASDAQ: AGMBHealthcareBiotechnologyUSD

8.80-0.04 (-0.45%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

AgomAb Therapeutics NV by the numbers

AgomAb Therapeutics NV has a market capitalization of $433.4 million based on 49.25M shares outstanding. With trailing EPS of $-2.08, AgomAb Therapeutics NV is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 31.0% below its 50-day average and 29.5% below its 200-day average.

Average daily trading volume is 137.04K shares, or about $1.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

AGMB valuation vs. peer median

AGMB compared with the median of 8 peer companies
Metric	AGMB	Peer median	Difference
Market cap	$433.38M	$432.23M	+0%
Avg. volume	137.04K	979.45K	-86%

Peer median across 8 companies: PRTA, ENTX, SPRY, DMAC, TECX, RZLT, EDIT, YDES.

Valuation

Market cap: $433.38M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-2.08
Shares outstanding: 49.25M

Price and trading

Previous close: 8.84
Open: 8.95
Day range: 8.68 – 9.35
52-week range: 7.97 – 17.82
50-day moving average: 12.76
200-day moving average: 12.48
Beta: —
Volume: 104.87K
Average volume: 137.04K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: —

Additional statistics

Market Cap: 433.38M
Forward Pe: -4.30
Eps: -2.08
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 17.82
Week52 Low: 7.97
Avg Volume: 137.04K
Shares Outstanding: 49.25M
Ma50: 12.76
Ma200: 12.48
Pct From52w High: -50.62%
Pct From52w Low: 10.41%